Publications by authors named "Prashasti Agrawal"

Claim this Profile
C
Clinicopathologic Characteristics and Clinical Outcomes of Patients with Testicular Mesothelioma.
Prashasti Agrawal, Fady Baky, Judy Sarungbam, Joel Sheinfeld, Victor E Reuter

Ann Surg Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes with neoadjuvant osimertinib and/or chemotherapy in patients with EGFR-mutant resectable non-small cell lung cancers.
Prashasti Agrawal, Julia Rotow, Gaetano Rocco, William Travis, Eduardo Ortiz

Lung Cancer· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Brief Report: Critical Role for DNA-Based Sequencing in Discriminating Distinct Primary Lung Cancers With Different MET Exon 14 Skipping Mutations.
Federica Pecci, Prashasti Agrawal, Jessica S Ross, Biagio Ricciuti, Seshiru Nakazawa

J Thorac Oncol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of eligibility criteria on KRASG12C inhibitor trials in patients with NSCLC.
Margaux Wooster, Michael May, Prashasti Agrawal, Jonathan Lee, Benjamin May

J Natl Cancer Inst· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes After Radiation for Oligoprogressive Disease Sites in Patients With -Mutant Lung Cancer Treated With Osimertinib.
Monica F Chen, Mark Y Jeng, Jennifer Ma, Prashasti Agrawal, Elizabeth Dunne

JCO Precis Oncol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combining a WT1 Vaccine (Galinpepimut-S) With Checkpoint Inhibition (Nivolumab) in Patients With WT1-Expressing Diffuse Pleural Mesothelioma: A Phase 1 Study.
Prashasti Agrawal, Michael Offin, Victoria Lai, Michelle S Ginsberg, Prasad S Adusumilli

JTO Clin Res Rep· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Older patients with primary central nervous system lymphoma: Survival and prognostication across 20 U.S. cancer centers.
Kevin A David, Suchitra Sundaram, Seo-Hyun Kim, Ryan Vaca, Yong Lin, Prashasti Agrawal

Am J Hematol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EBV-positive PCNSL in older patients: incidence, characteristics, tumor pathology, and outcomes across a large multicenter cohort.
Prashasti Agrawal, Kevin A David, Zhengming Chen, Suchitra Sundaram, Seo-Hyun Kim

Leuk Lymphoma· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Time on Therapy for at Least Three Months Correlates with Overall Survival in Metastatic Renal Cell Carcinoma.
Viola J Chen, Gabriela Hernandez-Meza, Prashasti Agrawal, Chiyuan A Zhang, Lijia Xie

Cancers (Basel)· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of UT-A1- and AQP2-interacting proteins in rat inner medullary collecting duct.
Chung-Lin Chou, Gloria Hwang, Daniel J Hageman, Lichy Han, Prashasti Agrawal

Am J Physiol Cell Physiol· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis